Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
MF | GO:0000146 | microfilament motor activity | 16/6507 | 22/17697 | 0.0006567 | 0.01091 | 0.008938 | 16 | RABC140 | |
MF | GO:0098960 | postsynaptic neurotransmitter receptor activity | 31/6507 | 52/17697 | 0.0006658 | 0.01091 | 0.008938 | 31 | RABC140 | |
MF | GO:0015378 | sodium:chloride symporter activity | 9/6507 | 10/17697 | 0.0008194 | 0.01257 | 0.0103 | 9 | RABC140 | |
MF | GO:0035615 | clathrin adaptor activity | 9/6507 | 10/17697 | 0.0008194 | 0.01257 | 0.0103 | 9 | RABC140 | |
MF | GO:0098748 | endocytic adaptor activity | 9/6507 | 10/17697 | 0.0008194 | 0.01257 | 0.0103 | 9 | RABC140 | |
MF | GO:0022824 | transmitter-gated ion channel activity | 35/6507 | 61/17697 | 0.0008271 | 0.01257 | 0.0103 | 35 | RABC140 | |
MF | GO:0022835 | transmitter-gated channel activity | 35/6507 | 61/17697 | 0.0008271 | 0.01257 | 0.0103 | 35 | RABC140 | |
MF | GO:0005201 | extracellular matrix structural constituent | 80/6507 | 163/17697 | 0.0008305 | 0.01257 | 0.0103 | 80 | RABC140 | |
KEGG | hsa05022 | Pathways of neurodegeneration - multiple diseases | 52/464 | 476/8135 | 0.00000338 | 0.0009245 | 0.0007486 | 52 | RABC41 | |
KEGG | hsa05130 | Pathogenic Escherichia coli infection | 28/464 | 197/8135 | 0.00000619 | 0.0009245 | 0.0007486 | 28 | RABC41 | |
KEGG | hsa05132 | Salmonella infection | 32/464 | 249/8135 | 0.0000118 | 0.0009245 | 0.0007486 | 32 | RABC41 | |
KEGG | hsa04141 | Protein processing in endoplasmic reticulum | 25/464 | 171/8135 | 0.0000119 | 0.0009245 | 0.0007486 | 25 | RABC41 | |
KEGG | hsa05135 | Yersinia infection | 21/464 | 137/8135 | 0.0000288 | 0.001797 | 0.001455 | 21 | RABC41 | |
KEGG | hsa05161 | Hepatitis B | 22/464 | 162/8135 | 0.0001223 | 0.006361 | 0.005151 | 22 | RABC41 | |
KEGG | hsa05160 | Hepatitis C | 21/464 | 157/8135 | 0.0002155 | 0.009604 | 0.007777 | 21 | RABC41 | |
KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 15/464 | 97/8135 | 0.0003579 | 0.01352 | 0.01095 | 15 | RABC41 | |
KEGG | hsa04722 | Neurotrophin signaling pathway | 17/464 | 119/8135 | 0.00039 | 0.01352 | 0.01095 | 17 | RABC41 | |
KEGG | hsa05010 | Alzheimer disease | 38/464 | 384/8135 | 0.0005713 | 0.01782 | 0.01443 | 38 | RABC41 | |
KEGG | hsa05020 | Prion disease | 29/464 | 273/8135 | 0.0008456 | 0.02399 | 0.01942 | 29 | RABC41 | |
KEGG | hsa05132 | Salmonella infection | 29/354 | 249/8135 | 0.00000108 | 0.0003261 | 0.0002784 | 29 | RABC42 | |
KEGG | hsa04210 | Apoptosis | 19/354 | 136/8135 | 0.00000599 | 0.0009039 | 0.0007719 | 19 | RABC42 | |
KEGG | hsa04071 | Sphingolipid signaling pathway | 17/354 | 119/8135 | 0.0000137 | 0.001383 | 0.001181 | 17 | RABC42 | |
KEGG | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 12/354 | 70/8135 | 0.0000415 | 0.002585 | 0.002208 | 12 | RABC42 | |
KEGG | hsa05130 | Pathogenic Escherichia coli infection | 22/354 | 197/8135 | 0.0000428 | 0.002585 | 0.002208 | 22 | RABC42 | |
KEGG | hsa04145 | Phagosome | 18/354 | 152/8135 | 0.0001 | 0.005034 | 0.004299 | 18 | RABC42 | |
KEGG | hsa00770 | Pantothenate and CoA biosynthesis | 6/354 | 21/8135 | 0.0002025 | 0.008736 | 0.00746 | 6 | RABC42 | |
KEGG | hsa04966 | Collecting duct acid secretion | 6/354 | 27/8135 | 0.0008852 | 0.02945 | 0.02515 | 6 | RABC42 | |
KEGG | hsa05216 | Thyroid cancer | 7/354 | 37/8135 | 0.0009255 | 0.02945 | 0.02515 | 7 | RABC42 | |
KEGG | hsa04010 | MAPK signaling pathway | 25/354 | 294/8135 | 0.0009927 | 0.02945 | 0.02515 | 25 | RABC42 | |
KEGG | hsa04142 | Lysosome | 62/1542 | 132/8135 | 0.000000000000155 | 0.0000000000514 | 0.0000000000267 | 62 | RABC1 |